- Home
- Publications
- Publication Search
- Publication Details
Title
New drug therapies in peripheral T-cell lymphoma
Authors
Keywords
-
Journal
Expert Review of Anticancer Therapy
Volume 11, Issue 3, Pages 457-472
Publisher
Informa UK Limited
Online
2011-03-21
DOI
10.1586/era.11.4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study
- (2010) A. Jaccard et al. BLOOD
- Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group
- (2010) N. Schmitz et al. BLOOD
- Phase II trial of zanolimumab (HuMax-CD4) in relapsed or refractory non-cutaneous peripheral T cell lymphoma
- (2010) Francesco D’Amore et al. BRITISH JOURNAL OF HAEMATOLOGY
- Interim report of a phase 2 clinical trial of lenalidomide for T-cell non-Hodgkin lymphoma
- (2010) Greg Dueck et al. CANCER
- Pralatrexate Is Synergistic with the Proteasome Inhibitor Bortezomib in In vitro and In vivo Models of T-Cell Lymphoid Malignancies
- (2010) E. Marchi et al. CLINICAL CANCER RESEARCH
- Phase III Placebo-Controlled Trial of Denileukin Diftitox for Patients With Cutaneous T-Cell Lymphoma
- (2010) H. Miles Prince et al. JOURNAL OF CLINICAL ONCOLOGY
- Final Results From a Multicenter, International, Pivotal Study of Romidepsin in Refractory Cutaneous T-Cell Lymphoma
- (2010) Sean J. Whittaker et al. JOURNAL OF CLINICAL ONCOLOGY
- StatBite: FDA Oncology Drug Product Approvals in 2009
- (2010) JNCI-Journal of the National Cancer Institute
- Sustained, durable responses with alemtuzumab in refractory angioimmunoblastic T-cell lymphoma
- (2010) Jennifer E. Amengual et al. LEUKEMIA & LYMPHOMA
- Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas
- (2010) Anas Younes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
- (2010) Eunice L. Kwak et al. NEW ENGLAND JOURNAL OF MEDICINE
- Alemtuzumab and DHAP (A-DHAP) is effective for relapsed peripheral T-cell lymphoma, unspecified: interim results of a phase II prospective study
- (2009) S. J. Kim et al. ANNALS OF ONCOLOGY
- Gemcitabine as single agent in pretreated T-cell lymphoma patients: evaluation of the long-term outcome
- (2009) P. L. Zinzani et al. ANNALS OF ONCOLOGY
- Variable CD52 expression in mature T cell and NK cell malignancies: implications for alemtuzumab therapy
- (2009) Liuyan Jiang et al. BRITISH JOURNAL OF HAEMATOLOGY
- A Phase II study of SGN-30 (anti-CD30 mAb) in Hodgkin lymphoma or systemic anaplastic large cell lymphoma
- (2009) Andres Forero-Torres et al. BRITISH JOURNAL OF HAEMATOLOGY
- Advances in the understanding and management of angioimmunoblastic T-cell lymphoma
- (2009) Laurence de Leval et al. BRITISH JOURNAL OF HAEMATOLOGY
- Epigenetic Modifiers: Basic Understanding and Clinical Development
- (2009) R. L. Piekarz et al. CLINICAL CANCER RESEARCH
- Cytotoxicity Mediated by Histone Deacetylase Inhibitors in Cancer Cells: Mechanisms and Potential Clinical Implications
- (2009) D. S. Schrump CLINICAL CANCER RESEARCH
- Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer Therapy
- (2009) M. H. Kang et al. CLINICAL CANCER RESEARCH
- Population Pharmacokinetics of Romidepsin in Patients with Cutaneous T-Cell Lymphoma and Relapsed Peripheral T-Cell Lymphoma
- (2009) S. Woo et al. CLINICAL CANCER RESEARCH
- Clinical Studies of Histone Deacetylase Inhibitors
- (2009) H. M. Prince et al. CLINICAL CANCER RESEARCH
- EBV-Related Lymphoproliferative Disease Complicating Therapy with the Anti-CD2 Monoclonal Antibody, Siplizumab, in Patients with T-Cell Malignancies
- (2009) D. O'Mahony et al. CLINICAL CANCER RESEARCH
- A Population Pharmacokinetic and Pharmacodynamic Evaluation of Pralatrexate in Patients With Relapsed or Refractory Non-Hodgkin's or Hodgkin's Lymphoma
- (2009) D R Mould et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Synergistic interaction of the histone deacetylase inhibitor SAHA with the proteasome inhibitor bortezomib in cutaneous T cell lymphoma
- (2009) Ulrike Heider et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy
- (2009) Thomas R Webb et al. Expert Review of Anticancer Therapy
- Phase II-I-II Study of Two Different Doses and Schedules of Pralatrexate, a High-Affinity Substrate for the Reduced Folate Carrier, in Patients With Relapsed or Refractory Lymphoma Reveals Marked Activity in T-Cell Malignancies
- (2009) Owen A. O'Connor et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma
- (2009) Richard L. Piekarz et al. JOURNAL OF CLINICAL ONCOLOGY
- The proteasome inhibitor bortezomib interacts synergistically with the histone deacetylase inhibitor suberoylanilide hydroxamic acid to induce T-leukemia/lymphoma cells apoptosis
- (2009) Q-L Zhang et al. LEUKEMIA
- CD52 expression in peripheral T-cell lymphomas determined by combined immunophenotyping using tumor cell specific T-cell receptor antibodies
- (2009) Eva Geissinger et al. LEUKEMIA & LYMPHOMA
- Current Status of Older and New Purine Nucleoside Analogues in the Treatment of Lymphoproliferative Diseases
- (2009) Tadeusz Robak et al. MOLECULES
- Temsirolimus in Mantle Cell Lymphoma and Other Non-Hodgkin Lymphoma Subtypes
- (2009) Georg Hess et al. SEMINARS IN ONCOLOGY
- L-Asparaginase in the treatment of refractory and relapsed extranodal NK/T-cell lymphoma, nasal type
- (2008) Weiben Yong et al. ANNALS OF HEMATOLOGY
- Complete response of relapsed angioimmunoblastic T-cell lymphoma following therapy with bevacizumab
- (2008) D. Aguiar Bujanda ANNALS OF ONCOLOGY
- Phase I study of proteasome inhibitor bortezomib plus CHOP in patients with advanced, aggressive T-cell or NK/T-cell lymphoma
- (2008) J. Lee et al. ANNALS OF ONCOLOGY
- Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials
- (2008) N. Mourad et al. BLOOD
- Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project
- (2008) W.-y. Au et al. BLOOD
- Histone Deacetylase Inhibitor Panobinostat Induces Clinical Responses with Associated Alterations in Gene Expression Profiles in Cutaneous T-Cell Lymphoma
- (2008) L. Ellis et al. CLINICAL CANCER RESEARCH
- Angioimmunoblastic T-cell lymphoma
- (2008) Emilio Iannitto et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Current and future aggressive peripheral T-cell lymphoma treatment paradigms, biological features and therapeutic molecular targets
- (2008) J. Rodríguez et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Zanolimumab, a human monoclonal antibody targeting CD4 in the treatment of mycosis fungoides and Sézary syndrome
- (2008) Dominik Sebastian Mestel et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Histone deacetylase inhibitors in lymphoma and solid malignancies
- (2008) Walid Rasheed et al. Expert Review of Anticancer Therapy
- International Peripheral T-Cell and Natural Killer/T-Cell Lymphoma Study: Pathology Findings and Clinical Outcomes
- (2008) JOURNAL OF CLINICAL ONCOLOGY
- Autologous Stem-Cell Transplantation As First-Line Therapy in Peripheral T-Cell Lymphomas: Results of a Prospective Multicenter Study
- (2008) Peter Reimer et al. JOURNAL OF CLINICAL ONCOLOGY
- Complete remission induced by thalidomide in a case of angioimmunoblastic T-cell lymphoma refractory to autologous stem cell transplantation
- (2008) Michele Gottardi et al. LEUKEMIA & LYMPHOMA
- Novel Therapies and Role of Transplant in the Treatment of Peripheral T-Cell Lymphomas
- (2008) S. M. Horwitz Hematology-American Society of Hematology Education Program
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search